Medpace FY26 Q2 net income rises to $121.36 million; revenue climbs 17.2% to $707.33 million - MEDP News | RalliesMedpace FY26 Q2 net income rises to $121.36 million; revenue climbs 17.2% to $707.33 million
M
MEDP• Quarterly results
- Medpace posted Q2 net income of USD 121.36 million, up USD 31.1 million from a year earlier.
- Revenue climbed 17.2% to USD 707.33 million, driven by growth in Metabolic, Oncology, CNS and AVAI programs.
- Operating income rose to USD 146.82 million; interest income, net more than doubled to USD 4.99 million.
Backlog and capital return
- Backlog increased 4.9% to USD 3.01 billion, with about USD 1.95 billion to USD 1.97 billion expected to convert within 12 months.
- Net new business awards reached USD 795.7 million; share repurchases totaled USD 294.7 million, leaving USD 527 million authorized.
